Healthcare
In recent years, the European healthcare industry has shown a consistently high level of innovation, accompanied by strong M&A activity. In particular, financial investors have shown high interest in acquisitions in this sector.
We have completed transactions in numerous segments, including nutraceuticals, health care services, pharmaceutical manufacturing and medical technology.
– Jan Wetter, Sector Head Healthcare
Pharmaceuticals
Healthcare Services
Medical Technology
Healthcare Transactions
View transactions
Close transactions
Proventis Partners advised Arion Group
Arion Group, an owner-managed company based on the border between the Netherlands and Germany, was sold to...
Proventis Partners advised the sellers of F. Hunziker + Co AG
Proventis Partners advises the sellers of F. Hunziker + Co AG on the sale to Amapharm GmbH.
PROVENTIS PARTNERS advised Rhenopharma Group
The acquired Konapharma AG, Allpack Group AG, and Rhenochem AG will form the Rhenopharma Group.
PROVENTIS PARTNERS advised OnlineDoctor AG
Proventis Partners acted as exclusive M&A advisor to the selling shareholders of OnlineDoctor AG, a leading tele-dermatology platform.
Proventis Partners advised BB Capital Investments
Proventis Partners advised Cosmetique Totale, a portfolio company of BB Capital Investments, on the purchase of MyDerma.
Proventis Partners advised ANK Group
Beyond Capital Partners acquires the majority of ANK Group, a leading medical supply chain group in Germany.
Proventis Partners advised Pflegehelden Group
Proventis Partners advised the shareholders and management of Pflegehelden Franchise GmbH and Pflegehelden Pflegedienst GmbH („Pflegehelden Group“) on the sale of their shares to Rigeto Unternehme
Proventis Partners advised H.I.G. Europe
H.I.G. Europe, acquired two leading European wheelchair manufacturers Meyra Group S.A. and Alu Rehab A/S.
Proventis Partners advised opTricon
Chembio Diagnostic Systems, Inc. acquired opTricon GmbH, manufacturer of optical analysis devices for point-of-care diagnostics.
Proventis Partners advised OMANDA
Proventis Partners advised OMANDA AG, a producer of medical whey protein shakes, on the financing of multiple clinical studies and further growth via a new investor.
Proventis Partners advised the buyer
Proventis Partners advised a German family holding on the acquisition of Medical Biomaterial Products GmbH, a manufacturer of medical devices for wound care.
Proventis Partners advised Eurocat
Proventis Partners advised the shareholders of Eurocat on the sale to the British Standards Institute.
Team Members Sector for
Healthcare
Get to know the team
Team Schließen
